Novo’ Nordisk’s drug to cut kidney disease advance in diabetics gets nod
Novo Nordisk’s medicine has been approved by the US drug regulator for reducing the risk of kidney failure and death due to cardiovascular.
Drugs
Health
Medical
Drugs
Pharma
Research
New insights on GLP-1 drugs: Benefits and risks unveiled
HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their.
Drugs
Medical
Research
India’s Tata Group grants $57.8 million to build medical school in IT capital
Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering.
Uncategorized
Novo Nordisk says its drug CargiSema cuts body weight by 22.7% in adults
Danish pharmaceutical company Novo Nordisk’s combination drug achieved a 22.7% weight-loss reduction compared to a dummy drug during end-stage trials, according to a.
Uncategorized
Eli Lilly to expand US facility as demand soars for diabetes, obesity medicines
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for.
Health
Lilly’s trial results for treating obesity and pre-diabetes are promising
HQ Team November 15, 2024: Eli Lilly’s Phase III trial has yielded positive results from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for.
Drugs
Health
Pharma
Global diabetic population rose fourfold to 828 million in 2022
The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.
Drugs
Health
Medical
One-third of West Africans have gene variants causing kidney disease
Researchers have found genomic variants in one-third of people from the West African countries of Ghana and Nigeria that significantly increase the risk.
Drugs
Health
Pharma
US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.
Climate
Drugs
Pharma
Denmark’s Novo Nordisk to invest $158 million in Brazil insulin facility
Novo Nordisk will invest 864 million reais ($158 million) to revamp its Brazil unit, which accounts for 25% of the drugmaker’s insulin shipments.